Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 400

1.

Angiographic derived endothelial shear stress: a new predictor of atherosclerotic disease progression.

Bourantas CV, Ramasamy A, Karagiannis A, Sakellarios A, Zanchin T, Yamaji K, Ueki Y, Shen X, Fotiadis DI, Michalis LK, Mathur A, Serruys PW, Garcia-Garcia HM, Koskinas K, Torii R, Windecker S, Räber L.

Eur Heart J Cardiovasc Imaging. 2018 Jul 17. doi: 10.1093/ehjci/jey091. [Epub ahead of print]

PMID:
30020435
2.

The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: A study of 142 cases.

Urano M, Hirai H, Tada Y, Kawakita D, Shimura T, Tsukahara K, Kano S, Ozawa H, Okami K, Sato Y, Fushimi C, Shimizu A, Takase S, Okada T, Sato H, Imanishi Y, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Sato Y, Saigusa N, Nakaguro M, Hanazawa T, Nagao T.

Histopathology. 2018 Jul 11. doi: 10.1111/his.13706. [Epub ahead of print]

PMID:
29993139
3.

Mouse Cre Models for the Study of Bone Diseases.

Dallas SL, Xie Y, Shiflett LA, Ueki Y.

Curr Osteoporos Rep. 2018 Jun 22. doi: 10.1007/s11914-018-0455-7. [Epub ahead of print] Review.

PMID:
29934753
4.

Retina-specific loss of Ikbkap/Elp1 causes mitochondrial dysfunction that leads to selective retinal ganglion cell degeneration in a mouse model of familial dysautonomia.

Ueki Y, Shchepetkina V, Lefcort F.

Dis Model Mech. 2018 Jun 21. pii: dmm.033746. doi: 10.1242/dmm.033746. [Epub ahead of print]

5.

Fluid shear stress suppresses ICAM-1-mediated transendothelial migration of leukocytes in coculture model.

Sakamoto N, Ueki Y, Oi M, Kiuchi T, Sato M.

Biochem Biophys Res Commun. 2018 Jul 20;502(3):403-408. doi: 10.1016/j.bbrc.2018.05.182. Epub 2018 May 31.

PMID:
29852173
6.

Reduced striatal dopamine release during motor skill acquisition in Parkinson's disease.

Kawashima S, Ueki Y, Kato T, Ito K, Matsukawa N.

PLoS One. 2018 May 30;13(5):e0196661. doi: 10.1371/journal.pone.0196661. eCollection 2018.

7.

Early treatment for IgG4-related disease may prevent cognitive impairment caused by cerebral vasculitis: A case report and review of the literature.

Usami T, Kawashima S, Ueki Y, Toyoda T, Okita K, Matsukawa N.

eNeurologicalSci. 2018 Jan 4;10:45-47. doi: 10.1016/j.ensci.2017.12.005. eCollection 2018 Mar.

8.

Feasibility of cardiovascular magnetic resonance to detect oxygenation deficits in patients with multi-vessel coronary artery disease triggered by breathing maneuvers.

Fischer K, Yamaji K, Luescher S, Ueki Y, Jung B, von Tengg-Kobligk H, Windecker S, Friedrich MG, Eberle B, Guensch DP.

J Cardiovasc Magn Reson. 2018 May 7;20(1):31. doi: 10.1186/s12968-018-0446-y.

9.

Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality.

Iba T, Arakawa M, Di Nisio M, Gando S, Anan H, Sato K, Ueki Y, Levy JH, Thachil J.

J Intensive Care Med. 2018 Jan 1:885066618773679. doi: 10.1177/0885066618773679. [Epub ahead of print]

PMID:
29720054
10.

Long-Term Assessment of Bioresorbable Coronary Scaffolds: Disappearing Stents, Reappearing Atherosclerosis.

Windecker S, Piccolo R, Ueki Y.

J Am Coll Cardiol. 2018 May 1;71(17):1894-1896. doi: 10.1016/j.jacc.2018.03.007. No abstract available.

PMID:
29699615
11.

Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model.

Yoshimoto T, Hayashi T, Kondo T, Kittaka M, Reichenberger EJ, Ueki Y.

J Bone Miner Res. 2018 Apr 18. doi: 10.1002/jbmr.3449. [Epub ahead of print]

PMID:
29669173
12.

Multicenter phase I/II study of chemoradiotherapy with high-dose CDDP for head and neck squamous cell carcinoma in Japan.

Matsuyama H, Yamazaki K, Okabe R, Ueki Y, Shodo R, Omata J, Sato Y, Ota H, Takahashi T, Tomita M, Yokoyama Y, Togashi T, Aoyama H, Abe E, Saijo Y, Katsura K, Soga M, Sugita T, Matsumoto Y, Tsuchida E, Horii A.

Auris Nasus Larynx. 2018 Oct;45(5):1086-1092. doi: 10.1016/j.anl.2018.02.008. Epub 2018 Mar 19.

PMID:
29567334
13.

Effect of auditory stimulus on executive function and execution time during cognitively demanding stepping task in patients with Parkinson's disease.

Watanabe T, Saito K, Ishida K, Tanabe S, Horiba M, Itamoto S, Ueki Y, Wada I, Nojima I.

Neurosci Lett. 2018 May 1;674:101-105. doi: 10.1016/j.neulet.2018.03.032. Epub 2018 Mar 17.

PMID:
29559418
14.

Rescue of a cherubism bone marrow stromal culture phenotype by reducing TGFβ signaling.

Liu Y, Sharma T, Chen IP, Reichenberger E, Ueki Y, Arif Y, Parisi D, Maye P.

Bone. 2018 Jun;111:28-35. doi: 10.1016/j.bone.2018.03.009. Epub 2018 Mar 9.

PMID:
29530719
15.

Reproducibility of acquiring ultrasonographic infant hip images by the Graf method after an infant hip ultrasound training course.

Shirai Y, Wakabayashi K, Wada I, Goto H, Ueki Y, Tsuchiya A, Tsuboi Y, Ha M, Otsuka T.

J Med Ultrason (2001). 2018 Mar 9. doi: 10.1007/s10396-018-0876-z. [Epub ahead of print]

PMID:
29524009
16.

Ultrasonographic efficacy of biologic and targeted synthetic DMARDs therapy in RA from multicenter RA ultrasound prospective cohort in Japan.

Nishino A, Kawashiri SY, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Yoshitama T, Eiraku N, Matsuoka N, Okada A, Fujikawa K, Hamada H, Tsuru T, Nagano S, Arinobu Y, Hidaka T, Kawakami A.

Arthritis Care Res (Hoboken). 2018 Feb 26. doi: 10.1002/acr.23551. [Epub ahead of print]

PMID:
29481732
17.

Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti-Human T Lymphotropic Virus Type I Antibody-Positive Rheumatoid Arthritis.

Suzuki T, Fukui S, Umekita K, Miyamoto J, Umeda M, Nishino A, Okada A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Fujikawa K, Aramaki T, Mizokami A, Matsuoka N, Ueki Y, Eguchi K, Sato S, Hidaka T, Origuchi T, Okayama A, Kawakami A, Nakamura H.

Arthritis Rheumatol. 2018 Jul;70(7):1014-1021. doi: 10.1002/art.40461. Epub 2018 May 25.

PMID:
29471588
18.

Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas.

Shimura T, Tada Y, Hirai H, Kawakita D, Kano S, Tsukahara K, Shimizu A, Takase S, Imanishi Y, Ozawa H, Okami K, Sato Y, Sato Y, Fushimi C, Takahashi H, Okada T, Sato H, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Ando M, Kohsaka S, Hanazawa T, Chazono H, Kadokura Y, Kobayashi H, Nagao T.

Oncotarget. 2017 Dec 4;9(2):1852-1867. doi: 10.18632/oncotarget.22927. eCollection 2018 Jan 5.

19.

Genetic Analysis of Human Norovirus Strains in Japan in 2016-2017.

Nagasawa K, Matsushima Y, Motoya T, Mizukoshi F, Ueki Y, Sakon N, Murakami K, Shimizu T, Okabe N, Nagata N, Shirabe K, Shinomiya H, Suzuki W, Kuroda M, Sekizuka T, Suzuki Y, Ryo A, Fujita K, Oishi K, Katayama K, Kimura H.

Front Microbiol. 2018 Jan 18;9:1. doi: 10.3389/fmicb.2018.00001. eCollection 2018.

20.

Establishing a New Screening System for Mild Cognitive Impairment and Alzheimer's Disease with Mental Rotation Tasks that Evaluate Visuospatial Function.

Suzuki A, Shinozaki J, Yazawa S, Ueki Y, Matsukawa N, Shimohama S, Nagamine T.

J Alzheimers Dis. 2018;61(4):1653-1665. doi: 10.3233/JAD-170801.

PMID:
29376869
21.

MicroRNA-204-3p inhibits lipopolysaccharide-induced cytokines in familial Mediterranean fever via the phosphoinositide 3-kinase γ pathway.

Koga T, Migita K, Sato T, Sato S, Umeda M, Nonaka F, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Masumoto J, Agematsu K, Yachie A, Yoshiura KI, Eguchi K, Kawakami A.

Rheumatology (Oxford). 2018 Apr 1;57(4):718-726. doi: 10.1093/rheumatology/kex451.

PMID:
29294109
22.

Phylogeny and Immunoreactivity of Norovirus GII.P16-GII.2, Japan, Winter 2016-17.

Nagasawa K, Matsushima Y, Motoya T, Mizukoshi F, Ueki Y, Sakon N, Murakami K, Shimizu T, Okabe N, Nagata N, Shirabe K, Shinomiya H, Suzuki W, Kuroda M, Sekizuka T, Ryo A, Fujita K, Oishi K, Katayama K, Kimura H.

Emerg Infect Dis. 2018 Jan;24(1):144-148. doi: 10.3201/eid2401.170284.

23.

Hepatitis B virus reactivation in patients with rheumatoid arthritis: A single-center study.

Matsuzaki T, Eguchi K, Nagao N, Tsuji S, Aramaki T, Terada K, Iwatsu S, Tokimura I, Kamo Y, Oda H, Kinoshita N, Miyaaki H, Taura N, Ichikawa T, Kawakami A, Nakao K, Ueki Y.

Mod Rheumatol. 2018 Jan 22:1-6. doi: 10.1080/14397595.2017.1419842. [Epub ahead of print]

PMID:
29256314
24.

Geriatric Nutritional Risk Index Predicts Cardiovascular Events in Patients at Risk for Heart Failure.

Minamisawa M, Miura T, Motoki H, Ueki Y, Nishimura H, Shimizu K, Shoin W, Harada M, Mochidome T, Senda K, Yoshie K, Oguchi Y, Hashizume N, Abe N, Saigusa T, Ebisawa S, Izawa A, Koyama J, Ikeda U, Kuwahara K.

Circ J. 2018 May 25;82(6):1614-1622. doi: 10.1253/circj.CJ-17-0255. Epub 2017 Dec 6.

25.

Tofacitinib Therapy for Rheumatoid Arthritis: A Direct Comparison Study between Biologic-naïve and Experienced Patients.

Mori S, Yoshitama T, Ueki Y.

Intern Med. 2018 Mar 1;57(5):663-670. doi: 10.2169/internalmedicine.9341-17. Epub 2017 Nov 20.

26.

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation.

Iba T, Hagiwara A, Saitoh D, Anan H, Ueki Y, Sato K, Gando S.

Ann Intensive Care. 2017 Nov 2;7(1):110. doi: 10.1186/s13613-017-0332-z.

27.

Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.

Yamaji K, Ueki Y, Souteyrand G, Daemen J, Wiebe J, Nef H, Adriaenssens T, Loh JP, Lattuca B, Wykrzykowska JJ, Gomez-Lara J, Timmers L, Motreff P, Hoppmann P, Abdel-Wahab M, Byrne RA, Meincke F, Boeder N, Honton B, O'Sullivan CJ, Ielasi A, Delarche N, Christ G, Lee JKT, Lee M, Amabile N, Karagiannis A, Windecker S, Räber L.

J Am Coll Cardiol. 2017 Nov 7;70(19):2330-2344. doi: 10.1016/j.jacc.2017.09.014.

PMID:
29096803
28.

Predictive Value of Underweight Status for Patients With Peripheral Artery Disease With Claudication.

Senda K, Miura T, Minamisawa M, Ueki Y, Mochidome T, Nomi H, Shoin W, Higuchi S, Oguchi Y, Nishimura H, Saigusa T, Ebisawa S, Motoki H, Izawa A, Koyama J, Ikeda U, Kuwahara K.

Angiology. 2018 Jul;69(6):513-522. doi: 10.1177/0003319717736627. Epub 2017 Oct 31.

PMID:
29088925
29.

Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis.

Fujita S, Mukai T, Mito T, Kodama S, Nagasu A, Kittaka M, Sone T, Ueki Y, Morita Y.

Bone. 2018 Jan;106:156-166. doi: 10.1016/j.bone.2017.10.017. Epub 2017 Oct 18.

PMID:
29055830
30.

CD4+ CD52lo T-cell expression contributes to the development of systemic lupus erythematosus.

Umeda M, Koga T, Ichinose K, Igawa T, Sato T, Takatani A, Shimizu T, Fukui S, Nishino A, Horai Y, Hirai Y, Kawashiri SY, Iwamoto N, Aramaki T, Tamai M, Nakamura H, Yamamoto K, Abiru N, Origuchi T, Ueki Y, Kawakami A.

Clin Immunol. 2018 Feb;187:50-57. doi: 10.1016/j.clim.2017.10.004. Epub 2017 Oct 13.

PMID:
29031579
31.

Characterization of conformational deformation-coupled interaction between immunoglobulin G1 Fc glycoprotein and a low-affinity Fcγ receptor by deuteration-assisted small-angle neutron scattering.

Yogo R, Yanaka S, Yagi H, Martel A, Porcar L, Ueki Y, Inoue R, Sato N, Sugiyama M, Kato K.

Biochem Biophys Rep. 2017 Aug 16;12:1-4. doi: 10.1016/j.bbrep.2017.08.004. eCollection 2017 Dec.

32.

Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification.

Takase S, Kano S, Tada Y, Kawakita D, Shimura T, Hirai H, Tsukahara K, Shimizu A, Imanishi Y, Ozawa H, Okami K, Sato Y, Sato Y, Fushimi C, Okada T, Sato H, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Hanazawa T, Chazono H, Osamura RY, Nagao T.

Oncotarget. 2017 Aug 2;8(35):59023-59035. doi: 10.18632/oncotarget.19812. eCollection 2017 Aug 29.

33.

Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts.

Kittaka M, Mayahara K, Mukai T, Yoshimoto T, Yoshitaka T, Gorski JP, Ueki Y.

J Bone Miner Res. 2018 Jan;33(1):167-181. doi: 10.1002/jbmr.3295. Epub 2017 Nov 2.

PMID:
28914985
34.

Effects of HLA-DRB1 alleles on susceptibility and clinical manifestations in Japanese patients with adult onset Still's disease.

Asano T, Furukawa H, Sato S, Yashiro M, Kobayashi H, Watanabe H, Suzuki E, Ito T, Ubara Y, Kobayashi D, Iwanaga N, Izumi Y, Fujikawa K, Yamasaki S, Nakamura T, Koga T, Shimizu T, Umeda M, Nonaka F, Yasunami M, Ueki Y, Eguchi K, Tsuchiya N, Tohma S, Yoshiura KI, Ohira H, Kawakami A, Migita K.

Arthritis Res Ther. 2017 Sep 12;19(1):199. doi: 10.1186/s13075-017-1406-x.

35.

Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals.

Mori S, Yoshitama T, Hirakata N, Ueki Y.

Clin Rheumatol. 2017 Dec;36(12):2673-2682. doi: 10.1007/s10067-017-3804-5. Epub 2017 Sep 7.

36.

Comparison of serum inflammatory cytokine concentrations in familial Mediterranean fever and rheumatoid arthritis patients.

Koga T, Kawashiri SY, Migita K, Sato S, Umeda M, Fukui S, Nishino A, Nonaka F, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Masumoto J, Agematsu K, Yachie A, Eguchi K, Kawakami A.

Scand J Rheumatol. 2018 Jul;47(4):331-333. doi: 10.1080/03009742.2017.1363281. Epub 2017 Sep 2. No abstract available.

PMID:
28868950
37.

A novel scoring system based on common laboratory tests predicts the efficacy of TNF-inhibitor and IL-6 targeted therapy in patients with rheumatoid arthritis: a retrospective, multicenter observational study.

Nakagawa J, Koyama Y, Kawakami A, Ueki Y, Tsukamoto H, Horiuchi T, Nagano S, Uchino A, Ota T, Akahoshi M, Akashi K.

Arthritis Res Ther. 2017 Aug 11;19(1):185. doi: 10.1186/s13075-017-1387-9.

38.

Ankle-brachial Index for the Prognosis of Cardiovascular Disease in Patients with Mild Renal Insufficiency.

Nishimura H, Miura T, Minamisawa M, Ueki Y, Abe N, Hashizume N, Mochidome T, Harada M, Shimizu K, Shoin W, Yoshie K, Oguchi Y, Ebisawa S, Motoki H, Izawa A, Koyama J, Ikeda U, Kuwahara K.

Intern Med. 2017 Aug 15;56(16):2103-2111. doi: 10.2169/internalmedicine.8215-16. Epub 2017 Aug 1.

39.

Optical coherence tomography- vs. intravascular ultrasound-guided percutaneous coronary intervention.

Räber L, Ueki Y.

J Thorac Dis. 2017 Jun;9(6):1403-1408. doi: 10.21037/jtd.2017.05.35. No abstract available.

40.

Erratum to: Animal and cellular models of familial dysautonomia.

Lefcort F, Mergy M, Ohlen SB, Ueki Y, George L.

Clin Auton Res. 2017 Aug;27(4):293. doi: 10.1007/s10286-017-0453-3. No abstract available.

PMID:
28717942
41.

Comparison of platelet aggregation response in switching regimen from prasugrel to clopidogrel between CYP2C19 extensive versus non-extensive metabolizers.

Ebisawa S, Ueki Y, Mochidome T, Senda K, Nishimura H, Saigusa T, Miura T, Motoki H, Koyama J, Ikeda U.

Cardiovasc Interv Ther. 2018 Jul;33(3):277-284. doi: 10.1007/s12928-017-0482-9. Epub 2017 Jul 5.

PMID:
28681220
42.

Animal and cellular models of familial dysautonomia.

Lefcort F, Mergy M, Ohlen SB, Ueki Y, George L.

Clin Auton Res. 2017 Aug;27(4):235-243. doi: 10.1007/s10286-017-0438-2. Epub 2017 Jun 30. Review. Erratum in: Clin Auton Res. 2017 Jul 17;:.

PMID:
28667575
43.

Multinuclear zinc bisamidinate catalyzed asymmetric alkylation of α-ketoesters and its unique chemoselectivity.

Yamanaka M, Inaba M, Gotoh R, Ueki Y, Matsui K.

Chem Commun (Camb). 2017 Jul 4;53(54):7513-7516. doi: 10.1039/c7cc01736g.

PMID:
28630967
44.

Impressive predictive value of ankle-brachial index for very long-term outcomes in patients with cardiovascular disease: IMPACT-ABI study.

Miura T, Minamisawa M, Ueki Y, Abe N, Nishimura H, Hashizume N, Mochidome T, Harada M, Oguchi Y, Yoshie K, Shoin W, Saigusa T, Ebisawa S, Motoki H, Koyama J, Ikeda U, Kuwahara K.

PLoS One. 2017 Jun 15;12(6):e0177609. doi: 10.1371/journal.pone.0177609. eCollection 2017.

45.

Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.

Mori S, Yoshitama T, Hidaka T, Sakai F, Hasegawa M, Hashiba Y, Suematsu E, Tatsukawa H, Mizokami A, Yoshizawa S, Hirakata N, Ueki Y.

PLoS One. 2017 Jun 8;12(6):e0179179. doi: 10.1371/journal.pone.0179179. eCollection 2017.

46.

Effect of High-Pressure Processing on Human Noroviruses in Laboratory-Contaminated Oysters by Bio-Accumulation.

Imamura S, Kanezashi H, Goshima T, Suto A, Ueki Y, Sugawara N, Ito H, Zou B, Uema M, Noda M, Akimoto K.

Foodborne Pathog Dis. 2017 Sep;14(9):518-523. doi: 10.1089/fpd.2017.2294. Epub 2017 Jun 8.

PMID:
28594572
47.

Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled.

Kawashiri SY, Fujikawa K, Nishino A, Okada A, Aramaki T, Shimizu T, Umeda M, Fukui S, Suzuki T, Koga T, Iwamoto N, Ichinose K, Tamai M, Mizokami A, Nakamura H, Origuchi T, Ueki Y, Aoyagi K, Maeda T, Kawakami A.

Arthritis Res Ther. 2017 May 25;19(1):108. doi: 10.1186/s13075-017-1320-2.

48.

Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan.

Koga T, Okada A, Fukuda T, Hidaka T, Ishii T, Ueki Y, Kodera T, Nakashima M, Takahashi Y, Honda S, Horai Y, Watanabe R, Okuno H, Aramaki T, Izumiyama T, Takai O, Miyashita T, Sato S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Nakamura H, Aoyagi K, Eguchi K, Kawakami A; Japanese RA Patients with RRP Study Group.

PLoS One. 2017 May 15;12(5):e0175281. doi: 10.1371/journal.pone.0175281. eCollection 2017.

49.

Molecular Evolution of the RNA-Dependent RNA Polymerase and Capsid Genes of Human Norovirus Genotype GII.2 in Japan during 2004-2015.

Mizukoshi F, Nagasawa K, Doan YH, Haga K, Yoshizumi S, Ueki Y, Shinohara M, Ishikawa M, Sakon N, Shigemoto N, Okamoto-Nakagawa R, Ochi A, Murakami K, Ryo A, Suzuki Y, Katayama K, Kimura H.

Front Microbiol. 2017 Apr 25;8:705. doi: 10.3389/fmicb.2017.00705. eCollection 2017.

50.

Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis.

Iwamoto N, Tsuji S, Takatani A, Shimizu T, Fukui S, Umeda M, Nishino A, Horai Y, Koga T, Kawashiri SY, Aramaki T, Ichinose K, Hirai Y, Tamai M, Nakamura H, Terada K, Origuchi T, Eguchi K, Ueki Y, Kawakami A.

PLoS One. 2017 May 4;12(5):e0177057. doi: 10.1371/journal.pone.0177057. eCollection 2017.

Supplemental Content

Support Center